The in vivo and in vitro effects of a hypoglycaemic fragment of human growth hormone containing the sequence H2N-Ile-Pro-Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met -Leu-COOH (hGH 4-15) on 2-deoxy-[1-14C]-D-glucose uptake in adipocytes were studied. The isolated cells from rats after a single intravenous injection of hGH 4-15 (1 mg/kg) significantly increased uptake of 2-deoxyglucose (p < 0.005). Adipocytes from untreated rats pre-incubated with the hGH fragment (10 ~tg/ml) at 37 °C for 30 min also clearly showed an elevated uptake of 2-deoxyglucose in the absence and the presence of exogenous insulin. The effect of hGH 4-15 was concentration-dependent, steadily increasing with the maximum effect at 10 gg/ml. The present findings suggest that the enhancement of glucose transport in target tissues may be a major contributing factor to the hypoglycaemic action of the amino-terminal fragments of human growth hormone.
Growth hormone (GH) displays a great variety of biological activities in vivo and in vitro. Hypoglycaemic activity of GH has long been documented [1] and has been shown to be due to insulin-synergistic action of the melecule [2] . The molecular mechanisms underlying the diverse in vivo actions of the hormone remain poorly understood, although many hypotheses have currently been proposed. The hypothesis that structural variants or discrete regions of the GH molecule are responsible for different biological actions is supported by a reasonable amount of experimental evidence [3] [4] [5] [6] . Studies with synthetic fragments of human growth hormone (hGH) suggest that the amino-terminal region of the molecule constitutes the active centre of the hormone for hypoglycaemic action [7] [8] [9] [10] . A comparative study of hypoglycaemic responses in rats with low circulating levels of GH revealed that both the intact molecule and the synthetic hGH 4-15 fragment affected the animals in an identical manner [11] . Hypoglycaemia represents only the end point of what must be a complex series of cellular and biochemical events. Evidence so far indicates that synthetic fragments of hGH containing the active sequence HzN-Arg-Leu-Phe-Asp-Asn-Ala-COOH induced hypoglycaemia as the result of modulating insulin receptor function and intracellular enzymic activities [12] [13] [14] [15] [16] [17] .
The present study was initiated to examine the effect of the hypoglycaemic hGH 4-15 on the glucose transport system, which is known as a major membrane regulatory component for overall glucose metabolism in target tissues. Impairment in glucose transport has been reported as a possible mechanism of insulin resistance in adipocytes of diabetic rats [18] . Furthermore, previous studies on glucose metabolism cannot be taken as a measure of glucose transport, since enhanced utilization of glucose by the activation of intracellular enzymes such as glycogen synthase has been shown to be independent of glucose transport [19] [20] [21] .
Materials and methods

Chemicals
Peptide hGH 4-15 was synthesized and purified as previously described [15] . Purified crystalline beef insulin was purchased from Commonwealth Serum Laboratories (Melbourne, Australia), bovine serum albumin (fraction V), trypsin and cytochalasin B from Sigma (St. Louis, Mo, USA), rabbit anti-insulin anti-serum (2 .ul/U/ml) from Miles Laboratories (Melbourne, Australia), collagenase (type 1) and neuraminidase from Worthington 
Animals
Male albino wistar rats of 100-120 g, housed under conditions of constant temperature (25 °C) with normal 12-h light cycle and fed ad libiturn, were used for the present work. For in vitro experiments animals were stunned by a blow to the head, decapitated, and epididymal fat pads removed for tissue experiments or preparations of isolated adipocytes. For the studies of the in vivo effects of hGH 4-15, animals were anaesthesized with an intraperitoneal injection of sodium pentobarbital (5 rag/100 g body wt) 30 rain prior to experimentation. The anaesthetized animals were then given intravenously a predetermined dose of the synthetic hGH fragment or saline (as control) for the indicated period of time before killing for tissue or cell preparations.
Preparation of isolated adipocytes
Isolated adipocytes were prepared from epididymal fat pads of control and hGH 4-15 treated rats by the method of Rodbell [22] . Adipocyte counts were performed according to the procedure as described by Foley et al. [23] .
Metabolism of glucose
The distal portions of epididymal fat pads were dissected into segments and incubated at 37 °C for 45 min in Krebs-Ringer bicarbonate buffer (pH 7.4) containing [U-14C]-D-glucose (5 uCi/~tmol), insulin and hGH 4-15 as indicated.
[14C]O2 production was measured as follows in the studies of glucose oxidation. The incubation was terminated by the injection of 200 ~tl of 5 M HzSO 4 through a rubber seal into the incubation vial. Immediately 200 ILl of hyamine hydroxide was injected onto a filter paper in the hanging well of the vial to collect the [~4C]O2 released. After a further incubation at 37 °C for 60 min, the filter paper roll was removed from the hanging well for radioactivity determination in a liquid scintillation counter. The similar incubation procedure was used for the estimation of glucose incorporation into lipid, [14C]-lipid in the tissues was extracted with 5 ml of chloroform: methanol (2 : 1) overnight at 4 °C. The fat pads were re-extracted twice with 2.5 ml of solvent mixture for 2 h. Non-lipid contaminants were removed by washing with methanol containing 0.005% MgC12 according to the method of Folch et al. [24] . The purified lipid extract was evaporated to dryness in a counting vial. Toluene scintillator was added and radioactivity was determined in a LKB liquid scintillation counter. Corrections for quenching were obtained by counting aliquots of different size and extrapolating to zero sample concentration as described by Jungas [25] . For enzyme assays, adipose tissues or isolated adipocytes were extracted by homogenization in a pH 7.6 buffer containing 50retool/1 triethanolamine hydrochloride, 5mmol/1 EDTA, 25 retool/1 NaF and 5 mmol/1 2-mercaptoethanol [26] . The supernatants were used for the determinations of glycogen synthase activity as described by Newman et al. [27] .
Glucose transport studies
Glucose transport in adipocytes was studied by using 2-deoxy-[1-amc]-D-glucose. To determine the basal or insulin-stimulated glucose transport in adipocytes from control and hGH 4 15 treated animals, suspensions at a concentration of 3-4 x 105 cells/ml were pre-incubated in the absence or the presence of insulin (10 .uU/ml) at 25 ° for 45 rain before assays. To test the in vitro effect of the hGH 4-15, normal adipocytes were pre-incubated with or without the hGH fragment (10 ~tg/ml) at 37 °C for 30 min. At the end of the pre-incubation the cells were washed and further incubated at 25 °C for 45 rain in the absence of the presence of insulin (10 ~tU/ml). The washing step would eliminate the possible molecular interaction between the hGH peptide and insulin, and it was necessary in the examination of the direct modulating action of hGH 4-15 on target cells. The assays were begun by adding 20 ~1 of radioactive labelled 2-deoxyglucose (final concentration 0A25 mmol/1) to the cells in 230 l-tl of Krebs-Ringer bicarbonate buffer containing 1% albumin. After incubation at 25 °C for 5 min, the hexose uptake was terminated by rapidly transferring 200 gl aliquots from the assay mixture to plastic microfuge tubes containing 100 ILl of dinonylphthalate. The tubes were centrifuged for 30 s in a Beckman microfuge and the assay was considered terminated when centrifugation began. The microfuge tubes were sliced at the viscous oil layer, and the radioactivity associated with the packed cells in the top layer was measured as described by Kobayashi and Olefsky [28] . The amount of 2-deoxy-[1-14C]-D-glucose trapped in the extracellular water space of the cell layers was determined with [3H] sorbitol or [3H] insulin according to the method of Gliemann [29] . All data for 2-deoxy-[1-14C]-D-glucose transport were corrected for this factor.
Statistical analysis
Values are given as means + SEM. Differences between means were analyzed with student's t-test for multiple comparisons and p values < 0.05 were considered significant.
Results
Effect of hGH 4-15 on glucose metabolism in adipose tissues and isolated adipocytes
Glucose oxidation, glycogen synthase activation and glucose incorporation into total lipid were increased after a single intravenous injection of hGH 4-15 (1 rag/ kg) as shown in Table 1 . The increase in the metabolic activities of the hGH 4-15 treated adipose tissues assayed under basal conditions revealed the in vivo metabolic modulation by the hGH fragment, possibly via endogenous insulin, as we had previously observed no effect of the hGH fragments in the streptozotocin-diabetic rats with undetectable levels of endogenous insulin [8] . The adipose tissues from hGH 4-15 treated animals were clearly more active in the three parameters tested in the presence of insulin; the percentage increase over the respective controls are 189% for glu- To determine the in vivo effect of hGH 4-15 on 2-deoxy-[1-a4C]-Dglucose transport, adipocytes were isolated from control and test animals treated in the identical manner as described for Table 1 . Suspensions at a concentration of 3-4 x 105 cells/ml were pre-incubated in the absence or the presence of insulin (10 ~U/ml) at 25 °C for 45 min before assays. The in vitro effect of the hGH fragment on radioactive labeled 2-deoxyglucose was demonstrated with normal adipocytes pre-incubated with or without hGH 4-15 (10 p,g/ml) at 37°C for 30 rain. At the end of the preincubation the ceils were washed and incubated at 25 °C an additional 45 min in the absence or the presence of insulin (10 p~U/ml). Assays were begun by adding 2-deoxyglucose at a final concentration of 0.125 mmol/1 and terminated at the end of 5 rain by rapidly transferring 200 ~tl aliquots from the assay mixture to plastic microtube containing 100 pJ of dionylphthalate for a 30 s centrifugation in a microfuge. All values are corrected for extracellular water space as indicated in Materials and methods. The data represent the mean _+ SEM of five separate experiments performed in quadruplicate cose oxidation, 120% for glycogen synthase activation and 173% for glucose incorporation into lipid. The hGH 4-15 treated adipose tissues appeared to have a significantly high level of the active form (I) of glycogen synthase even when assayed under basal condition (p< 0.005). This is similar to our previous observation in skeletal muscle [12] . Table 2 reveals the in vitro actions of hGH 4-15. The hGH peptide (10~tg/ml) significantly increased glucose oxidation and glycogen synthase activation in isolated adipocytes both in the presence and the absence of exogenous insulin (p< 0.05).
Effect of h G H 4-15 on 2-deoxy-D-[ 14 C]glucose transport in isolated adipocytes
The in vivo and in vitro effects of hGH 4-15 on 2-deoxy-[1-a4C]-D-glucose transport in adipocytes were demonstrated under basal conditions and in the presence of 10 p~U/ml of insulin ( [19] ; no intracellular 2-deoxy-[1-aac]-D-glucose was detected and essentially all the intracellular deoxyglucose was in phosphorylated form (chromatograms not shown). It has been well recognized that at high concentrations of extracellular glucose, transport may not be considered rate-limiting step for glucose metabolism [30] [31] [32] . Therefore, 0.1 retool/1 of glucose analogue was used in this study. It should also be pointed out that the concentration of insulin was 10 btU/ml, which was much smaller than that usually reported in literature on glucose transport in isolated cells. At this low concentration of exogenous insulin, the rate of 2-deoxyglucose transport was not significantly different from the basal rate in the absence of hGH 4-15, and that enabled us to clearly demonstrate the effect of the hGH peptide. The adipocytes isolated from the hGH 4-15 treated animals showed a significant increase of 2-deoxy- Table 3 . Results expressed as mean + SEM of three experiments carried out in quadruplicate peared to be necessary for the optimal effect of the hGH peptide. The data further indicated that hGH 4-15 might have a direct effect on the transport system in adipocytes.
To verify the ability of hGH 4-15 to affect basal transport of 2-deoxy-[1-14C]-D-glucose, isolated adipocytes were pre-treated with anti-insulin sera. The hGH fragment at a concentration of 10 ~xg/ml gave a significant increase of 2-deoxyglucose transport of the serumtreated cells (Fig.3, p<0.025) . Trypsinization destroys insulin receptors and virtually eliminates the effect of insulin on various metabolic functions in cells. Nevertheless, the present finding shows that hGH 4-15 slightly enhanced the transport of 2-deoxy-[1-14C]-D-glucose by trypsinized adipocytes. Evidence clearly indicates that hGH 4-15 was able to enhance 2-deoxyglucose transport over the basal level.
Data also demonstrate that the specific glucose transport inhibitor, cytochalasin B, abolished the stimulatory effect of hGH 4-15 on 2-deoxy-[1-14C]-D-glucose uptake. In addition, adipocytes pre-incubated with neuraminidase (10 btg/ml) at 37 °C for 30 min failed to respond to hGH 4-15. Our previous studies have shown that the synthetic peptide hGH 4--15 induced hypoglycaemia in rats of different age groups [11] . Evidence also revealed that at the molecular level the synthetic peptide increased insulin receptor function and glycogen synthase activity [12] . The effect of the hGH 4-15 on glucose transport had not been firmly established. It is generally believed that the increase of insulin binding to plasma membrane receptors could result in alteration in transport processes [33] . However, the molecular relationship between insulin receptors and glucose transporters remains to be elucidated. Neuraminidase decreased glucose transport and oxidation without any inhibitory effect on insulin receptor binding [34] [35] [36] . Concanavalin A inhibited insulin binding but stimulated glucose transport [37, 38] . Many other agents such as cytochalasin B and trypsin have been shown to haw~ opposite effects on these two membrane-related metabolic regulators, namely the insulin receptor and the glucose transporter [39] [40] [41] [42] . The present study is therefore essential in establishing unequivocally the effect of the amino-terminal sequence of hGH on glucose transport system of target cells. The initial findings revealed the similarities between in vivo and in vitro responses of the adipose tissues to hGH 4-15 in glucose oxidation, glycogen synthesis and lipogenesis, thus suggested that isolated adipocytes would be a suitable cell type for the studies on glucose transport. This was confirmed with the evidence that the in vivo effect of hGH 4-15 on 2-deoxyglucose transport in adipocytes remained in the subsequently isolated cells. The present work demonstrates that the synthetic hGH 4-15 stimulates basal as well as insulin-stimulated 2-deoxyglucose transport of isolated rat adipocytes. The retention of increased transport rates in adipocytes of treated animals implies that the peptide has conferred a modification in the transport system. Currently the precise molecular mechanism underlying the action of hGH 4-15 on the transport system is not yet elucidated.
The in vitro results also clearly show that exposure of the isolated adipocytes to hGH 4-15 appears to bring about, through some as yet unknown mechanism, an increase of 2-deoxyglucose transport in the presence of submaximal concentration of exogenous insulin. The increase was related to the concentration of hGH 4-15, and maximum effect was observed at a concentration of 10 .ug/ml. The inhibition of 2-deoxyglucose transport by cytochalasin B in both the absence and the presence of hGH 4-15 revealed that the hGH fragment has no effect in the absence of functional transporters. The neuraminidase data suggest that the transport proteins, presumably in the plasma membrane, might be involved the effect of the hGH 4-15. As the enhancing effect of these amino-terminal fragments of hGH on insulin receptor function was well established in our previous studies [11, 12] , it was easy to speculate that the alteration in transport process could be a result of enhanced insulin binding to its receptor. However, the present data indicate that hGH 4-15 still stimulated 2-deoxyglucose transport in trypsinized adipocytes. As it is generally known that trypsin inactivates insulin receptor at plasma membrane and reduces insulin binding to isolated cells, this finding suggests that hGH 4-15 stimulated glucose transport independently from its effects of the insulin receptors. Experiments on adipocytes pretreated with anti-insulin anti-serum further confirmed that hGH 4-15 was able to stimulate 2-deoxyglucose transport in the cells by a mechanism which was independent of insulin. This is compatible with the observation on the effect of hGH 4-15 on trypsinized adipocytes. It is quite conceivable that hGH 4-15, in addition to its effect on membrane receptors and transporters, acts upon a distal intracellular event in glucose metabolism.
The data in this study, together with our earlier findings [11] , clearly show that the amino-terminal fragments of hGH enhance glucose transport, glucose utilization and insulin binding in rat adipocytes. Interestingly, hGH has recently been reported to have the same biological effect in vitro on adipocytes only after prolonged pre-incubation [43, 44] . Without prolonged preincubation, the adipocytes appeared to remain in the refractory state and failed to respond to the insulin-like actions of the intact hGH [45] . The precise mechanism to explain refractoriness in target cells is still obscure. Evidence from the present and the previous studies [81 on hGH fragments showed that isolated cells as welt as intact animals responded rapidly to the actions of hGH 4-15. It is possible that the refractory state may be associated with a temporary impairment of the cellular mechanism to initiate the modulation of hGH into a functional confirmation or the proteolytic release of the active fragments of the hormonal molecule for the biological actions. However, our current observation is consistent with the concept that the amino-terminal region of the hGH molecule may be responsible for the insulin-potentiating action of the hormone. This concept is further supported by the recent observation by Forigeri that hGH 1-43 has potent insulin-potentiating action as reported by Lewis [10] . Further, the findings from the present studies with hGH 4-15 not only offer additional support that the insulin-potentiating fragments of hGH may have therapeutic potential in the treatment of diabetes mellitus, but also further our understanding of the molecular actions of intact hGH.
